Peptide MechanismsPeptide Immunogenicity in Immune Response
In 2023, the FDA flagged three peptides as substances warranting caution, citing immunogenicity risk among concerns for compounds that had never undergone formal clinical safety assessment—an acknowledgment that peptide immunogenicity and immune response dynamics remain poorly understood outside con
AdminUpdated Aug 510 min
